The prognostic role of ploidy status, S phase fraction, estrogen and progesterone receptor
status, and the expression of p 53 and erbB-2 protein in male breast carcinoma (MBC) …

BACKGROUND: It is unclear whether breast cancer has a similar prognosis in males and
females. METHODS: A 20-year retrospective study of all male breast cancer patients in our …

Male breast cancer is a rare clinical entity accounting for approximately 1 per cent of all
breast cancers. The present study investigated changes in patient characteristics, disease …

BACKGROUND Although breast cancer in men is far less common than breast cancer in
women, it is associated with a less favorable prognosis. Conventional histopathologic …

Background: Considerable debate exists concerning the prognosis of breast cancer in male
patients compared with that in female patients. Some studies have observed worse …

Male breast cancer is rare, and experience of it in any single institution is limited. Our current
understanding regarding its biology, natural history, and treatment strategies has been …

Male mammary carcinoma (MMC) affects approximately 1000 men in the United States each
year. Aside from the impact of estrogen-receptor positivity on the clinical course of this tumor …

Background Male breast cancer has traditionally been compared with female breast cancer,
using the same staging system and prognostic indicators. A variety of histochemical and …

Introduction Male breast cancer (MBC) is a rare, yet potentially aggressive disease.
Although literature regarding female breast cancer (FBC) is extensive, little is known about …

Male breast cancer is a rare disease. The aim of this study was to compare overall survival
(OS) and disease‑free survival (DFS) in a group of matched males and females with breast …